This webinar covers financial strategies for running a sustainable psychedelic therapy practice, with an emphasis on compliance, planning, and growth. It is a 1-hour session offering 2 CE credits.
Fluence
English
1 Hour
Practical Finance for Psychedelic Therapy: Compliance, Planning & Growth is a Fluence webinar focused on the financial side of running a psychedelic therapy practice. The session centers on compliance, planning, and business growth. The course is designed for practitioners and professionals involved in psychedelic therapy who need a clearer framework for managing practice finances. It presents practical strategies for sustainability rather than clinical content. The listed format is a 1-hour webinar, and the page indicates 2 CE credits. No certificate, scholarship, or pricing details are provided in the source excerpt.
Practitioners and professionals involved in psychedelic therapy who need a clearer framework for managing practice finances.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
By Therapsil
Focused short-form trainings in psychedelic safety, harm reduction, and clinical skill. One listed topic is Psychedelic First Aid, presented in collaboration with Neuma Centre.
Next cohort: May 20, 2026